Mark Titus - Concepedia

Author

Mark Titus

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Bai, Suxia, Kafri, Tal, Kawinski, Elzbieta, M. A. Titus, M. TITUS, M. Titus, M.A. Titus, MARK TITUS, Mark A Titus, Mark A. Titus

166

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Roswell Park Comprehensive Cancer Center University at Buffalo, State University of New York UNC Lineberger Comprehensive Cancer Center University of North Carolina at Chapel Hill

About

Mark Titus is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, urology, and endocrinology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	1.2K
2	Natural Sciences	3	3	63
3	Biochemistry	3	3	74
4	Health Sciences	2	2	37
5	Public Health	1	1	97

Mark Titus

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer Mark Titus, Michael J. Schell, Fred B. Lih, Clinical Cancer Research	2005	490
Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer Eleni Efstathiou, Mark Titus, Sijin Wen, European Urology Molecular CharacterizationUrologyMedicineAnti-cancer AgentProstatic Disease	2014	246
Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation Neeraj K. Saxena, Mark Titus, Xiaokun Ding, The FASEB Journal Hepatic Stellate CellsApoptosisImmunologyCell DeathPathology	2004	210
Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone Eleni Efstathiou, Mark Titus, Dimitra Tsavachidou, Journal of Clinical Oncology	2011	187
Steroid 5α-Reductase Isozymes I and II in Recurrent Prostate Cancer Mark Titus, Christopher W. Gregory, O. Harris Ford, Clinical Cancer Research	2005	173
Activation of the Androgen Receptor by Intratumoral Bioconversion of Androstanediol to Dihydrotestosterone in Prostate Cancer James L. Mohler, Mark Titus, Suxia Bai, Cancer Research	2011	148
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy Christopher P. Vellano, Michael G. White, Miles C. Andrews, Nature Hormonal ReceptorBreast CancerPharmacotherapyEndocrinologyMedicine	2022	124
Non-Cell-Autonomous Regulation of Prostate Epithelial Homeostasis by Androgen Receptor Boyu Zhang, Oh-Joon Kwon, Gervaise H. Henry, Molecular Cell Androgen ReceptorUrologySignal TransductionHormonal ReceptorProstatic Disease	2016	105
5α‐reductase type 3 expression in human benign and malignant tissues: A comparative analysis during prostate cancer progression Alejandro Godoy, Elzbieta Kawinski, Yun Li, The Prostate	2010	102
SPERMAGGLUTININ FORMATION IN MALE RATS BY SUBCUTANEOUSLY INJECTED SYNGENEIC EPIDIDYMAL SPERMATOZOA AND BY VASOLIGATION OR VASECTOMY P Rümke, Mark Titus Reproduction SpermatogenesisFertilityGynecologySemen AnalysisReproductive Biology	1970	97

Page 1